Stay updated on Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.

Latest updates to the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page
- Check6 days agoChange DetectedThe page now lists Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's revision/version metadata rather than changes to visible content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s footer revision indicator was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check63 days agoChange Detected- Revision tag updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision: v3.4.3 updated from the previous v3.4.2.SummaryDifference0.0%

- Check99 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing the previous v3.4.1. No study details or user interactions are affected.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.